Ready to find the right treatment? Upload medical records & instantly get program matches.

Brain & Rare Cancer Treatment Options When Standard Care Runs Out

A plain-language guide for patients and families facing a brain tumor or a rare cancer: what to ask, how to find expert opinions, and how pre-approval access pathways work.

For brain tumors such as glioblastoma, and for rare cancers like sarcomas, there are often fewer approved options and fewer specialists who see these diseases every day. When standard treatment stops working, finding the right experts and asking precise questions can make a real difference to what is discussed next.

This guide explains the questions worth bringing to your oncologist, how to find a second opinion from a specialist team, and how the FDA’s pre-approval pathways work, so you can approach the next step with clearer information.

What to ask your oncologist

Questions specific to brain or rare cancer:

  • Has my tumor had full molecular and genomic profiling, and has the pathology been reviewed by a specialist pathologist?
  • Could the results point to approved options used for other cancers with the same molecular change?
  • Is there a specialist center that treats many patients with my exact diagnosis?
  • For a brain tumor: are there surgical, radiation, or device-based options we have not discussed?
  • How can we manage symptoms such as seizures, fatigue, or pain and protect quality of life?

Questions worth asking for any advanced cancer:

  • What are the goals of treatment from here: control, symptom relief, or comfort?
  • Are there any approved options we have not yet discussed, including ones used off-label?
  • Would you support me getting a second opinion, and who would you recommend?
  • Would a pre-approval pathway such as expanded access or Right to Try be worth discussing for me?
  • Can we bring in palliative and supportive care now, alongside any other treatment?

FDA expanded access and Right to Try

When approved options have been exhausted, U.S. law offers two pathways that may let a doctor request a medical product that is not yet FDA-approved, outside of a research study. FDA expanded access, often called compassionate use, involves FDA review of each request and, generally, an ethics committee (IRB). The federal Right to Try Act (2018) created a separate, narrower pathway for people with life-threatening conditions that does not require FDA review of the individual request.

Both pathways share three facts worth knowing: a licensed physician must make the request and oversee care, the manufacturer must agree to provide the product and is not required to, and unapproved products are not proven safe or effective and may not help.

Learn more in our guides to FDA expanded access (compassionate use) and Right to Try.

Getting a second opinion

A second opinion is a normal part of cancer care, and most oncologists welcome it. It can confirm the diagnosis, check that testing is complete, and surface approved options or approaches that were not discussed. With rare cancers, a review by a center that sees many cases of your exact diagnosis, including a specialist pathology review, is often one of the most valuable next steps.

Many NCI-designated cancer centers offer remote second opinions based on your records, and insurance often covers them. Ask your insurer and the center before you schedule.

How to prepare for the conversation

  1. Gather your recordsRequest your pathology reports, biomarker and genetic test results, imaging reports (and the image files), and a summary of every treatment you have received with dates.
  2. Write down your questionsBring a written list and put the most important questions first. Appointments move quickly.
  3. Bring a second set of earsA family member or friend can take notes, or ask whether you may record the conversation.
  4. Know your prioritiesThink about what matters most to you, such as time at home, travel limits, or side effects you want to avoid, and say it out loud.
  5. Agree on next stepsBefore you leave, confirm who will do what, by when, and how to reach the care team with follow-up questions.

Support resources

You do not have to navigate this alone. These organizations offer free information and support:

Palliative care focuses on comfort, symptoms, and quality of life. It can begin at any stage and can be given alongside other treatment, so ask for it early.

Frequently asked questions

Why does a specialist pathology review matter for rare cancers?

Rare cancers can be difficult to classify, and an expert pathologist may refine the diagnosis or identify molecular features that change which approved options are worth discussing.

How do I find a specialist for a brain tumor or rare cancer?

Ask your oncologist for a referral, contact NCI-designated cancer centers, or reach out to disease-specific patient organizations, which often keep lists of experienced centers and offer remote second opinions.

What can I do when standard brain or rare cancer treatments stop working?

Ask your oncologist whether every approved option has been considered, request a second opinion at a specialized cancer center, and ask whether a pre-approval pathway such as FDA expanded access or Right to Try could be appropriate. Supportive and palliative care can be part of the plan at any stage.

What is FDA expanded access (compassionate use)?

Expanded access is an FDA pathway that may let a patient with a serious or life-threatening condition receive a not-yet-approved medical product outside of a research study, when no comparable approved therapy is available. A licensed physician makes the request, the manufacturer must agree, and the FDA reviews it.

Can I request expanded access or Right to Try on my own?

No. Both pathways require a licensed physician to make the request and oversee care, and in both cases the manufacturer must agree to provide the product. Your role is to learn how the pathways work and start the conversation with your doctor.

Does Right2Hope provide treatment or guarantee access?

No. Right2Hope is a free educational nonprofit. We do not provide medical care, determine eligibility, or guarantee access to any treatment. Unapproved treatments have not been established as safe or effective and may not help.

About this guide

Last updated: . Published by Right2Hope, a 501(c)(3) nonprofit. All patient services are free.

Medical disclaimer: This page is for general educational information only and is not medical advice. Right2Hope does not provide medical care, determine eligibility, or guarantee access to any treatment, and no treatment discussed here is promised to work. Unapproved treatments have not been established as safe or effective and may carry serious or unknown risks. Always make treatment decisions with a licensed physician who knows your medical history.